Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses.
Reports vary on how close Steven Gerrard is to being appointed Rangers boss, while Besiktas are reportedly interested in ...
The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.
Bayer hopes to release its new knockdown herbicide, icafolin-methyl, in Australia in 2028, subject to APVMA approvals and ...
BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in ...
TipRanks on MSN
Regeneron and Bayer Complete Long-term Study on Retinopathy of Prematurity Treatments
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals, in ...
TipRanks on MSN
Oracle Commodity Holding Corp. Appoints New VP Legal and Announces Leadership Changes
Oracle Commodity Holding Corp. ( ($TSE:ORCL) ) has provided an update. Oracle Commodity Holding Corp. has appointed Stephanie Lee as Vice ...
TEAMtalk on MSN
Netherlands 4-0 mauling gives Slot two ideas for Liverpool changes – both involve Salah
The Netherlands' 4-0 pumping of Malta - in which over a third of the starting eleven contained Liverpool players - could give ...
The Duchenne Muscular Dystrophy Drugs Market presents opportunities in advanced genetic therapies, digital health, and ...
Bangkok Post on MSN
Early Detection Vital to Prevent Vision Loss
On the occasion of “World Sight Day,” a leading ophthalmologist is highlighting two major but often overlooked eye conditions ...
Argentina and Colombia secure their spots in the U-20 quarter-finals with wins over Nigeria and South Africa, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback